scispace - formally typeset
A

Atsuo Waki

Researcher at National Institute of Radiological Sciences

Publications -  17
Citations -  690

Atsuo Waki is an academic researcher from National Institute of Radiological Sciences. The author has contributed to research in topics: Cell culture & 3D cell culture. The author has an hindex of 11, co-authored 17 publications receiving 627 citations. Previous affiliations of Atsuo Waki include University of Fukui.

Papers
More filters
Journal ArticleDOI

The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation

TL;DR: A 3D culture system with inorganic nanoscale scaffolding using nanoimprinting technology (nano-culture plates) allows creating uniform and highly-reproducible 3D cultures, which can be used for high-throughput/high-content screening of anticancer drugs and should accelerate discovery of more effective anticancer therapies.
Journal ArticleDOI

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.

TL;DR: This work investigated the relation between [14C]choline metabolism and proliferative activity using 10 tumor cell lines and fibroblasts and found that choline uptake was higher in tumor cells than in fibro Blasts and was correlated with the proliferativeActivity, though the sensitivity of [14 cCholine uptake to proliferation activity was less than that of [1-14C]-acetate.
Journal ArticleDOI

Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism

TL;DR: It is found that tumor cells expressed higher levels of cytosolic acetyl‐CoA synthetase (ACSS2) under hypoxia than normoxia, which indicates that ACSS2 is a bi‐directional enzyme in tumor cells and that AC SS2 might play a buffering role in tumor acetyl-CoA/acetate metabolism.
Journal ArticleDOI

Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome

TL;DR: It is demonstrated that uptake of radiolabeled acetate is a useful predictor of FASN-targeted therapy outcome, which suggests that [1-11C]acetate positron emission tomography (PET) could be a powerful tool to accomplish personalized FASn- targeted therapy by non-invasive visualization of tumor acetate uptake and selection of responsive tumors.
Journal ArticleDOI

High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.

TL;DR: An innovative high-throughput screening system using nanoimprinting 3D culture to simulate in vivo conditions, thereby facilitating efficient drug development and developing drugs that effectively inhibit cancer growth in vivo as compared to 2D culture is reported.